Ongoing projects

Ongoing Projects

BANGLADESH: Led by FAO from 1 January 2023 to 1 January 2026

Bangladesh’s project focuses on strengthening systems for optimized use of antimicrobials, improving capacity to design awareness raising and behaviour change and strengthening systems for generating data for policymakers.

Key activities include:

Expanding of antimicrobial stewardship programs to selected secondary and tertiary hospitals ;
Developing multisectoral communication strategies including developing and disseminating awareness materials on AMR/AMU in Bengali (human, terrestrial and aquatic animals, and environment health sectors);
Conducting national/subnational AMU/AMC data collection training/workshops with participants from key stakeholders in terrestrial animals, aquatic animals, and human health sectors

ETHIOPIA: Led by FAO from 25 May 2021 to 25 May 2024

Ethiopia’s project sets out to strengthen AMR related policy frameworks and governance, scale up AMR surveillance in the human and animal health sectors, strengthen systems for infection prevention control and biosecurity as well as optimizing antimicrobial use.

Key activities include:

Supporting the country’s AMR governance structures (coordination committee, inter-ministerial committee, sub/national AMR advisory committee) and monitor the implementation of the One Health Ethiopian AMR strategy;
Strengthening the human and animal health national AMR surveillance system;
Strengthening health care associated infections (HAI) prevention and control in 20 hospitals;
Developing and implementing of standards on food safety, biosecurity, infection prevention, and hygiene guidelines;
Training of medicine regulatory bodies on market surveillance and control, regulatory inspection and sensitization on the impacts of substandard and falsified antimicrobials.

GHANA: Led by WHO from 24 May 2021 to 24 February 2024

Ghana’s project emphasizes activities to strengthen the country’s surveillance and data-analysis capacity, support the development of biosecurity standards, improve prudent AMU and design communication and awareness-raising activities.

Key activities include:

Establishing surveillance systems for AMU in humans, animals, crops and the environment;
Assessing laboratory capacity for conducting culture and sensitivity testing, as well as capacity for hospital-based surveillance;
Developing national biosecurity standards to enhance AMS at farm level;
Developing guidelines for the use of national surveillance data for rational selection and responsible use of antimicrobials in human and animal health;
Developing Information, Education and Communication materials for targeted groups and the public.

MADAGASCAR: Led by WHO from 1 January 2023 to 1 January 2026

Madagascar’s project focuses on outcomes and outputs related to the impact created in terms of behaviour change, including improved infection prevention and control, the use of antimicrobial alternatives, and the rational use of antimicrobials. It also addresses some of the main areas of concern in Madagascar, namely the use of illicit, substandard and falsified medicines across sectors. It thus contributes to promoting the rational use of antimicrobials, in accordance with the AMR NAP.

Key activities include:

Strengthening systems for generating, analyzing and interpreting data on resistance and consumption/use patterns ;
Improving the country’s capacity for designing and implementing AMR-related policy frameworks, investment plans and programmes;
Improving the capacity to design awareness-raising, behaviour-change and educational activities;
Strengthening Systems for biosecurity and IPC.

MONGOLIA: Led by WHO from 1 January 2023 to 1 January 2026

Mongolia was reported to have the highest antibiotic consumption in the Western Pacific Region. Mongolia’s project focuses on strengthening systems for optimized use of antimicrobials, improving capacity to design awareness raising and behaviour change and strengthening systems for generating data for policymakers.

Key activities include:

Establishing an effective governance system to combat AMR;
Strengthening surveillance and diagnostic capacity for AMR and research;
Reducing the spread of infections through better infection prevention and control;
Raise awareness and understanding of AMR with the general public, herdsmen and health professionals;
Developing and implementing multi-sectoral communication strategies and plans based on AMR surveillance and AMC/AMU monitoring.

SENEGAL: Led by FAO from 17 January 2022 to 17 January 2024

Senegal’s project focuses on strengthening AMR and AMU data collection and analysis, and improved infection prevention control and biosecurity.

Key activities include:

Building an M&E and lesson learning framework for AMR and AMU data collection and reporting;
Capacity assessment of 10 laboratories for AMR detection in human, animal and environment sectors;
Implementing a surveillance strategy for AMR to support AMU/AMR data collection and reporting systems;
Development and dissemination of good practice measures on biosecurity, and guidelines on IPC;
Strengthening the capacity of the National Medicines Commission and the National Pharmacovigilance One Health Commission in the regulation and registration of antimicrobial drugs;
Supporting 15 joint missions of the National Committee to control, collect and test the quality of medicines in the market.

TAJIKISTAN: Led by WHO from 5 August 2021 to 5 August 2024

Tajikistan’s project focuses on strengthening the country’s AMR surveillance, improving the prudent use of antimicrobials, improving IPC, WASH and biosecurity and raising awareness about antimicrobial resistance and use.

Key activities include:

Developing and expanding AMR surveillance in human and animal health, food and the environment;
Strengthening laboratory capacity by undertaking training for professionals working in public health, veterinary and food safety;
Reviewing and updating the national Essential Medicines List;
Improving antimicrobial use and good husbandry practices of farmers and veterinarians;
Supporting the development of national standards for IPC core components in healthcare facilities;
Supporting the implementation of good biosecurity, husbandry, and management practices in priority livestock production systems.

TUNISIA: Led by FAO from 1 January 2023 to 1 January 2026

Tunisia’s project focuses on improving capacities for designing and implementing AMR-related policy frameworks, investment plans and programs, strengthening systems for generating, analyzing and interpreting data and improved capacity to design awareness-raising, behaviour change and educational activities.

Key activities include:

Supporting the establishment and functioning of the national inter-ministerial AMR steering committee in Tunisia;
Strengthening the management and monitoring capacities of NAP activities through joint workshops on AMR Management ;
Strengthening the national AMR/AMU surveillance system in Tunisia for better monitoring planning, data collection, processing and dissemination to key stakeholders ;
Assessing, designing and supporting implementation of traceability system of antimicrobials in human health, animal health, plant protection and environment sectors;
Developing and implementing a joint communication plan to raise awareness on AMR by ensuring equitable participation between men and women and by respecting the participation of people with disabilities including organizing training of key stakeholders in human health, animal health, plant protection and environment on AMR, good practices, biosecurity and infection control.

ZIMBABWE: Led by FAO from 21 May 2021 to 21 May 2024

Zimbabwe’s project focuses on strengthening the country’s systems for biosecurity and IPC, improving the prudent use of antimicrobials and raising awareness about the issue among the public and key stakeholders.

Key activities include:

Revising the national IPC policy and strategic plan, the national IPC guidelines and training programme;
Developing and implementing biosecurity and hygiene standards in animal husbandry;
Conducting supply-chain mapping of the distribution of human and veterinary medicines and securing the supply chain to prevent the entry of substandard and falsified medicines into the country;
Undertaking KAP studies to understand key drivers of AMR in the country;
Designing and delivering targeted awareness-raising activities, training and education to key stakeholder groups.